Investor Presentaiton

117 Investor presentation Full year 2022 Diabetes market share and market growth in EMEA 75% 50% 25% Diabetes market growth and Novo Nordisk market share 0% Nov 2019 EMEA DKK Diabetes market size and growth billion 20% ~16% 17% 6 115 5 16% 5 99 99 15% 10% 31% 29% 5% ~17% 29% 29% 0% Nov Nov Novo Nordisk AZ Others Nov 2022 2021 2022 Novo Nordisk Competitors -NN market share -Market growth (right axis) NN share of growth NN growth (right axis) Source: IQVIA, Nov 2022, Value, MAT, EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; AZ- Astra Zeneca

View entire presentation